Un-Pledge and Sale of ESOP Shares Is a Trade—Not Contra Trade | SEBI Clarifies

Informal Guidance No. SEBI/HO/ISD/OW/2025/20748/1, Dated: 04.08.2025

A company approached SEBI seeking clarity on whether the release of pledge over ESOP shares held by its Managing Director (MD), followed by their sale, would amount to trades or contra trades under the SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations).

1. SEBI’s Response

SEBI confirmed that:

• Release of pledge and
• Subsequent sale of ESOP shares

are treated as “trades” for the purposes of PIT Regulations.

However, such actions will not qualify as “contra trades” because there is no change in beneficial ownership of shares at the time of pledge creation or release.

2. Regulatory Implications

Although contra trade restrictions are not triggered, the following compliance requirements still apply:

• Pre-clearance of trades as per the company’s internal code of conduct
• No possession of Unpublished Price Sensitive Information (UPSI) at the time of trade
• Adherence to all other conditions and reporting obligations under the PIT Regulations
• Disclosures as required under law and company policy

3. Key Takeaway

Unpledging and sale of ESOP shares by a designated person (such as an MD) will be categorised as trading activity but will not amount to contra trade, since the beneficial ownership of shares remains unchanged throughout the pledge duration.

Click Here To Read The Full Update